Cat. No. 4056
Chemical Name: [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,
Biological ActivityBinds and stabilizes microtubules; leads to cell cycle arrest and apoptosis. Displays significant antitumor activity in ovarian and gastric tumors. Prevents microtubule depolymerization and disassembly in the absence of GTP. Exhibits cytotoxic activity.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Lyseng-Williamson and Fenton (2005) Docetaxel: a review of its use in metastatic breast cancer. Drugs 65 2513. PMID: 16296875.
Ramaswamy and Puhalla (2006) Docetaxel: a tubulin-stabilizing agent approved for the management of several solid tumors. Drugs Today (Barc) 42 265. PMID: 16703123.
If you know of a relevant citation for this product please let us know.
Keywords: Docetaxel, supplier, cancer, therapy, antitumor, binds, stabilizes, microtubules, microtubule, stabilizer
Find multiple products by catalog number
New Products in this Area
Inhibitor of actin polymerizationIspinesib
High affinity and selective allosteric KSP inhibitorBRD 9876
ATP non-competitive kinesin Eg5 inhibitorBTB1
Selective and ATP-competitive Kif18A inhibitor
July 7 - 11, 2015
Rio de Janeiro, Brazil